TNF and irritable bowel syndrome: The most abundant of these, acetate, propionate, and butyrate, which make up over >95% of SCFA in humans (53), are markedly decreased in IBD patients (54), while their exogenous delivery can reduce inflammation via inhibition of TNF-α release from neutrophils (51, 55).